|
rs10403955
|
CYP2B6
|
Intronic CYP2B6 haplotype-tagging variant associated with altered plasma conc...
|
Pharmacogenomics
|
|
Moderate
|
|
rs1058164
|
CYP2D6
|
Synonymous CYP2D6 variant that promotes exon 3 skipping, reducing functional ...
|
Pharmacogenomics
|
|
Moderate
|
|
rs1065852
|
CYP2D6
*10
|
Decreased function CYP2D6 variant common in Asian populations
|
Pharmacogenomics
|
|
Established
|
|
rs1360780
|
FKBP5
Intronic C>T
|
Co-chaperone of the glucocorticoid receptor that regulates cortisol feedback ...
|
Mood & Behavior
|
|
Strong
|
|
rs1080985
|
CYP2D6
*2A promoter
|
CYP2D6 promoter variant (-1584C>G) that reduces enzyme expression; the C alle...
|
Pharmacogenomics
|
|
Strong
|
|
rs1387923
|
NTRK2
NTRK2/TrkB 3'UTR variant
|
3' UTR variant in the TrkB receptor gene affecting NTRK2 expression; associat...
|
Mood & Behavior
|
|
Moderate
|
|
rs12248560
|
CYP2C19
*17
|
Increased function CYP2C19 variant - rapid/ultrarapid metabolizer
|
Pharmacogenomics
|
|
Established
|
|
rs1800544
|
ADRA2A
ADRA2A Promoter -1291C>G
|
Promoter variant that alters alpha-2A adrenergic receptor expression, affecti...
|
Appetite & Obesity
|
|
Moderate
|
|
rs12721627
|
CYP3A4
*16
|
Missense variant reducing CYP3A4 enzyme activity by 50–74% depending on subst...
|
Pharmacogenomics
|
|
Moderate
|
|
rs16947
|
CYP2D6
*2
|
Common CYP2D6 variant defining the *2 allele; previously considered normal-fu...
|
Pharmacogenomics
|
|
Strong
|
|
rs2371365
|
PCLO
PCLO Presynaptic Scaffold
|
Intronic variant in the presynaptic scaffold gene PCLO linked to altered mono...
|
Mood & Behavior
|
|
Moderate
|
|
rs2522833
|
PCLO
Ser4814Ala
|
Missense variant in the C2A calcium-binding domain of presynaptic scaffolding...
|
Mood & Behavior
|
|
Moderate
|
|
rs25531
|
SLC6A4
A>G
|
Promoter SNP near 5-HTTLPR that modifies serotonin transporter expression and...
|
Mood & Behavior
|
|
Moderate
|
|
rs2069526
|
CYP1A2
-739T>G
|
Intronic CYP1A2 variant near the 5' end; G allele is associated with altered ...
|
Pharmacogenomics
|
|
Emerging
|
|
rs6295
|
HTR1A
C-1019G
|
Functional promoter variant in the serotonin 1A receptor gene that increases ...
|
Mood & Behavior
|
|
Strong
|
|
rs6311
|
HTR2A
-1438G>A
|
Regulatory variant in serotonin 2A receptor gene affecting SSRI side effects ...
|
Mood & Behavior
|
|
Moderate
|
|
rs28371706
|
CYP2D6
*17
|
Decreased-function CYP2D6 allele common in African populations, reducing meta...
|
Pharmacogenomics
|
|
Established
|
|
rs28371725
|
CYP2D6
*41
|
Intronic splice variant causing decreased CYP2D6 enzyme activity through aber...
|
Pharmacogenomics
|
|
Established
|
|
rs28371733
|
CYP2D6
|
Rare CYP2D6 stop-gain variant (Glu418Ter) that eliminates enzyme activity, ca...
|
Pharmacogenomics
|
|
Established
|
|
rs28695233
|
CYP2D6
|
Deep intronic CYP2D6 variant in intron 2 that serves as a haplotype tag in sp...
|
Pharmacogenomics
|
|
Emerging
|
|
rs35599367
|
CYP3A4
*22
|
Intronic splice variant causing ~50% reduced CYP3A4 mRNA expression, affectin...
|
Pharmacogenomics
|
|
Established
|
|
rs373489637
|
CYP2B6
V183G
|
Near-complete loss-of-function CYP2B6 variant causing severely impaired metab...
|
Pharmacogenomics
|
|
Moderate
|
|
rs3745274
|
CYP2B6
516G>T
|
Decreased-function variant affecting metabolism of efavirenz, methadone, bupr...
|
Pharmacogenomics
|
|
Established
|
|
rs3758581
|
CYP2C19
Ile331Val (CYP2C19*1B)
|
Common CYP2C19 missense variant defining the *1B allele; the G (Val331) allel...
|
Pharmacogenomics
|
|
Moderate
|
|
rs5443
|
GNB3
C825T
|
Synonymous exon-10 variant that triggers alternative splicing of the G-protei...
|
Hormones & Sleep
|
|
Strong
|
|
rs3892097
|
CYP2D6
*4
|
CYP2D6 *4 splice-defect null allele — the most common loss-of-function CYP2D6...
|
Pharmacogenomics
|
|
Established
|
|
rs4244285
|
CYP2C19
*2
|
No-function CYP2C19 variant affecting PPIs, clopidogrel, and some antidepress...
|
Pharmacogenomics
|
|
Established
|
|
rs4986893
|
CYP2C19
*3
|
No-function CYP2C19 stop-gain variant — second most common loss-of-function a...
|
Pharmacogenomics
|
|
Established
|
|
rs5030655
|
CYP2D6
*6
|
Frameshift deletion causing no enzyme function, defining poor metabolizer sta...
|
Pharmacogenomics
|
|
Established
|
|
rs58440431
|
CYP2D6
|
Intronic CYP2D6 variant tagging East Asian *10-lineage suballeles; the C alle...
|
Pharmacogenomics
|
|
Strong
|
|
rs71328650
|
CYP2D6
|
Intronic CYP2D6 haplotype tag variant (rs28371702 canonical form) associated ...
|
Pharmacogenomics
|
|
Emerging
|
|
rs72549354
|
CYP2D6
*20
|
Frameshift insertion creating a null CYP2D6 allele; carriers cannot metaboliz...
|
Pharmacogenomics
|
|
Established
|